Charles Schwab
CRTX

Charles Schwab’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Charles Schwab’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-18,100
Closed -$172K – 3090
2013
Q4 		$172K Hold
18,100
– – ﹤0.01% 2989
2013
Q3 		$172K Hold
18,100
– – ﹤0.01% 2962
2013
Q2 		$147K Buy
+18,100
New +$153K ﹤0.01% 2989

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Charles Schwab's CRTX Position: Q1 2014 in Review

Charles Schwab sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 18,100 shares — an estimated $172K sold.

Charles Schwab first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $172K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Charles Schwab reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Charles Schwab sold 18,100 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $172K.
  • Charles Schwab first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Charles Schwab's CORNERSTONE THERAPEUTICS INC position peaked at $172K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Charles Schwab's 13F filing for Q1 2014, filed 29 Apr 2014.